←Back to Expert Scholars
Translational Medicine / 转化医学Hodgkin Lymphoma
Martin Hutchings
MD, PhD
🏢Rigshospitalet, Copenhagen🌐Denmark
Senior Consultant, Department of Hematology
70
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Martin Hutchings is a pioneer of interim PET-adapted therapy in Hodgkin lymphoma and has led multiple international studies optimizing response-adapted treatment. He is also an investigator for novel bispecific antibody therapies in lymphoma.
Share:
🧪Research Fields 研究领域
PET-adapted therapy
interim PET
bispecific antibodies
Scandinavian lymphoma trials
response-adapted therapy
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Martin Hutchings 的研究动态
Follow Martin Hutchings's research updates
留下邮箱，当我们发布与 Martin Hutchings（Rigshospitalet, Copenhagen）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment